Re: Inflammatory markers and the risk of Alzheimer disease: the Framingham Study

Neurology. 2008 Apr 1;70(14):1222-3; author reply 1223. doi: 10.1212/01.wnl.0000307660.86647.7b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / immunology*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Biomarkers / analysis
  • Biomarkers / blood
  • Brain / immunology
  • Brain / metabolism
  • Brain / physiopathology
  • Encephalitis / complications
  • Encephalitis / immunology*
  • Humans
  • Leukocytes, Mononuclear / immunology*
  • Leukocytes, Mononuclear / metabolism
  • Longitudinal Studies
  • Predictive Value of Tests
  • Risk Factors
  • Synaptic Transmission / immunology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers
  • Tumor Necrosis Factor-alpha